U.S. Assisted Living Facility Market Size, Share & Trends Analysis Distribution by Age (More than 85, 75-84, 65-74, Less than 65) and Segment Forecasts, 2025-2034
U.S. Assisted Living Facility Market Size is valued at USD 103.5 Bn in 2024 and is predicted to reach USD 182.3 Bn by the year 2034 at a 5.9% CAGR during the forecast period for 2025-2034. Assisted Living Facilities (ALFs) in the United States provide housing, personalized support services, and healthcare to older adults who require assistance with daily activities but do not need the level of care provided in nursing homes. These facilities off...
Report ID: 2616 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 175
Peptide–Drug Conjugates (PDCs) Market Size, Share & Trends Analysis Report Product Type (Radiopharmaceutical PDCs, Cytotoxic PDCs, Diagnostic PDCs, Emerging PDCs), By Therapeutic Application (Oncology, Neuroendocrine Tumors, Prostate Cancer, Solid Tumors, Hematologic Cancers, Neurological Disorders, Metabolic Diseases, Infectious Diseases), Type, Product, By Region, And By Segment Forecasts, 2025-2034
The Peptide–Drug Conjugates (PDCs) Market Size is valued at USD 3.80 Bn in 2024 and is predicted to reach USD 21.10 Bn by the year 2034 at a 18.8 % CAGR during the forecast period for 2025-2034. The emergence of Peptide–Drug Conjugates (PDCs) therapy for patients suffering from different cancers is believed to create several clinical opportunities during the forecast period. Peptide drug conjugates comprise three vital components: ...
Report ID: 1351 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
ATMP Service Providers Market Size, Share & Trends Analysis Report By Type Of Service (Analytics, Quality, CMO, Logistics), By Application (GTMP, sCTMP, TEP), Region And Segment Forecasts, 2025-2034
ATMP Service Providers Market Size is valued at 16.68 Billion in 2024 and is predicted to reach 42.57 Billion by the year 2034 at a 9.9% CAGR during the forecast period of 2025-2034. Advanced Therapy Medicinal Products (ATMPs) are therapies for human consumption with an active therapeutic substance that may be based on the technology to modify a patient's genome, recombinant nucleic acids or genes, engineered tissue and substantially manipulat...
Report ID: 1228 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 150
Digital Chemical Industry Market Size, Share & Trends Analysis Report By Technology (Internet of Things (IoT), 3D Printing, Augmented Reality (AR), Virtual Reality (VR), Artificial Intelligence, Digital Twin, Others), By Verticals, By Process, By Region, And Segment Forecasts, 2025-2034
Global Digital Chemical Industry Market Size is valued at USD 19.1 Billion in 2024 and is predicted to reach USD 140.8 Billion by the year 2034 at a 22.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The adoption of Internet of Things technology in the chemical industry is a significant driver for the digital chemical industry market. Growing environmental concerns, the focus on reducin...
Report ID: 1190 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
CGRP Inhibitor Market Size, Share Detailed Report 2025 to 2034
Global CGRP Inhibitor Market Size is valued at USD 3.3 Bn in 2024 and is predicted to reach USD 8.5 Bn by the year 2034 at a 10.2% CAGR during the forecast period for 2025 to 2034. CGRP Inhibitor Market Size, Share & Trends Analysis Report By Treatment (Preventive, Acute), By Route of Administration (Oral, Nasal, Intravenous), By End-User (Hospitals, Pharmacies, Specialty Clinics), By Region, And By Segment Forecasts, 2025 to 2034 CGRP in...
Report ID: 2984 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Medication Adherence Market Size, Share & Trends Analysis Report by Type (Hardware Centric, and Software Centric), Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, and Others),, Region And Segment Forecasts, 2025-2034
Global Medication Adherence Market Size is valued at USD 4.1 billion in 2024 and is predicted to reach USD 16.2 billion by the year 2034 at a 14.9% CAGR during the forecast period for 2025-2034. The market for medication adherence is projected to see significant growth as leading companies pursue strategic initiatives such as alliances and business expansions in undeveloped areas. The aging population, increased healthcare spending, increased ph...
Report ID: 2125 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 179
Contraceptive Market Size, Share & Trends Analysis Report By Product( Contraceptive Drugs(Contraceptive Pills, Patch, Injectables), Contraceptive Devices(Condoms(Male Condoms, Female Condoms), Subdermal Implants, IUDs(Copper IUDs, Hormonal IUDs), Vaginal Rings, Diaphragm), By Region, And Segment Forecasts, 2025-2034
Global Contraceptive Market Size is valued at USD 32.5 Billion in 2024 and is predicted to reach USD 69.0 Billion by the year 2034 at a 7.9% CAGR during the forecast period for 2025-2034. The use of contraception has increased, which has improved health outcomes, such as maternal and newborn mortality, and reduced the risk of STDs. Additionally, it is projected that an increase in the number of gynecologists who support these contraceptive metho...
Report ID: 1494 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Genetic Genealogy Market Size, Share & Trends Analysis Report By Test Type (Autosomal DNA Test, Y- chromosome DNA Test, Mitochondrial DNA Test), By Application (Heredity & Genetic Disorders, Paternal/Maternal Lineages, Ancestral Origins, Others), By End User (Direct-to-Consumer Testing Companies, Law Enforcement Agencies, Research Institutes & Academic Organizations, Others), Region And Segment Forecasts, 2025-2034
Genetic Genealogy Market Size is valued at USD 971.17 Mn in 2024 and is predicted to reach USD 2187.61 Mn by the year 2034 at an 8.5% CAGR during the forecast period for 2025-2034. Numerous benefits of genetic analysis make it more necessary than ever among the global population. Genetic analysis offers possible medical benefits and assists patients, cancers, and healthcare providers in modifying the therapy and healthcare given to an individu...
Report ID: 2059 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Neuroimmunology Drugs Market Size, Share & Trends Analysis Distribution by Disease Focus (Multiple Sclerosis (MS), Neuromyelitis Optica Spectrum Disorder (NMOSD), Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Amyotrophic Lateral Sclerosis (ALS), Autoimmune Encephalitis, Other Rare Neuroimmune Disorders), Therapeutic Approach, Mechanism of Action, Development Stage, Delivery Method, CNS-Targeted, Biomarker Integration and Segment Forecasts, 2025-2034
The Neuroimmunology Drugs Market Size is valued at US$ 25.6 Bn in 2024 and is predicted to reach US$ 63.3 Bn by the year 2034 at an 9.7% CAGR during the forecast period for 2025-2034. The Neuroimmunology Drugs Market is growing very fast, driven by increasing knowledge of the complex interaction between the immune and nervous systems. These drugs are targeted to modulate immune reactions in neurological diseases resulting from immune dys...
Report ID: 1171 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Neoantigen Peptides Manufacturing Market Size, Share & Trends Analysis Report By Scale of Operations (Research/Preclinical, Clinical, Commercial), By End-Users (Pharmaceutical/Vaccine developers companies, Contract Research Organizations, Academic and research institutes, Region And Segment Forecasts, 2025-2034
Global Neoantigen Peptides Manufacturing Market Size is valued at USD 1.4 Billion in 2024 and is predicted to reach USD 6.3 Billion by the year 2034 at a 16.4% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The increasing prevalence of cancer as well as other chronic illnesses is a major factor driving the growth of the neoantigen peptides manufacturing market. Rapid progre...
Report ID: 1270 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 170
Pharmaceuticals